Summary of COVID-19 medicines guidance: Learning disabilities

This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and learning disabilities.

Our advice is constantly reviewed as the pandemic situation evolves.

Whilst we have tried to ensure that the information on this page is complete, please report a concern if you feel anything is omitted or inaccurate.

To see our professional guidance summaries for other clinical areas, click here

Advice in this area includes:

NHS England/NHS Improvement: this has been moved to the NICE website.

Last updated: 24 March 2020

NICE: Management of patients with a learning disability, autism or both

Last updated: New as of November 2020, but info still dated 24 March 2020

  • This resource contains no information relating to specific medicines.

Administration update (11th November 2020): administrative amendments made to the page only.